Whales with a lot of money to spend have taken a noticeably bearish stance on Recursion Pharmaceuticals.
Looking at options history for Recursion Pharmaceuticals (NASDAQ:RXRX) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 55% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $136,560 and 7, calls, for a total amount of $373,205.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $5.0 and $13.0 for Recursion Pharmaceuticals, spanning the last three months.
Volume & Open Interest Trends
In terms of liquidity and interest, the mean open interest for Recursion Pharmaceuticals options trades today is 1912.33 with a total volume of 8,438.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Recursion Pharmaceuticals's big money trades within a strike price range of $5.0 to $13.0 over the last 30 days.
Recursion Pharmaceuticals Option Activity Analysis: Last 30 Days
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | CALL | TRADE | BULLISH | 01/15/27 | $5.5 | $5.0 | $5.3 | $5.00 | $106.0K | 5.8K | 200 |
| RXRX | PUT | SWEEP | BULLISH | 09/19/25 | $4.0 | $3.8 | $3.8 | $11.00 | $101.4K | 252 | 269 |
| RXRX | CALL | TRADE | BULLISH | 06/20/25 | $1.8 | $1.55 | $1.75 | $9.00 | $65.6K | 2.7K | 377 |
| RXRX | CALL | SWEEP | BEARISH | 01/15/27 | $5.5 | $5.3 | $5.3 | $5.00 | $50.8K | 5.8K | 305 |
| RXRX | CALL | TRADE | BEARISH | 04/17/25 | $0.35 | $0.25 | $0.25 | $13.00 | $50.0K | 18 | 1.5K |
About Recursion Pharmaceuticals
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
After a thorough review of the options trading surrounding Recursion Pharmaceuticals, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Recursion Pharmaceuticals's Current Market Status Currently trading with a volume of 10,087,972, the RXRX's price is up by 4.74%, now at $8.53. RSI readings suggest the stock is currently may be approaching overbought. Anticipated earnings release is in 2 days. Expert Opinions on Recursion Pharmaceuticals
1 market experts have recently issued ratings for this stock, with a consensus target price of $11.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $11.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Recursion Pharmaceuticals options trades with real-time alerts from Benzinga Pro.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
